OR WAIT null SECS
December 25, 2024
Revised guidelines published by EMA and HMA update the rules on identification of commercially confidential information and personal data used in marketing authorization applications.
December 24, 2024
Emer Cooke, executive director of EMA, is encouraged by the competitiveness of the European pharmaceutical market.
December 17, 2024
A pilot program to explore creation and testing of ePIs in regulatory procedures shows positive results.
December 16, 2024
EMA recommended 17 drugs for marketing authorization in December, including treatments for rare heart conditions, anemia, and liver disease.
December 13, 2024
The company will be showcasing its injection blow molded bottles and five-layer blown film at the packaging event in Paris on Jan. 22–23, 2025.
December 12, 2024
With these agreements, the respective parties will work to advance therapeutic candidates for treating fibrotic diseases, osteoarthritis, and Alzheimer’s disease.
With this investment, BioMarin will add a new laboratory to its Shanbally, Co. Cork, Ireland, manufacturing facility.
December 11, 2024
The European Commission has approved Novo Holdings' acquisition of Catalent, which includes the related sale of three manufacturing sites to Novo Nordisk, which is also acquiring the Czech Republic manufacturing site of Novavax for $200 million.
December 04, 2024
The agency’s safety committee found no sufficient evidence of causal relationship between the antibiotic doxycycline and the risk of suicide or suicidal thoughts.
The European Commission has developed a roadmap aimed at reversing the rising trend of cancer across the European Union.